T1	Participants 203 260	periodontal infections with systemic antimicrobial agents
T2	Participants 685 739	Patients who had high proportions of spirochetes, i.e.
T3	Participants 741 798	> 20%, in plaques removed from diseased periodontal sites
T4	Participants 1269 1280	18 patients
